480 related articles for article (PubMed ID: 22016541)
1. Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1.
Park CK; Lü N; Xu ZZ; Liu T; Serhan CN; Ji RR
J Neurosci; 2011 Oct; 31(42):15072-85. PubMed ID: 22016541
[TBL] [Abstract][Full Text] [Related]
2. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1.
Park CK; Xu ZZ; Liu T; Lü N; Serhan CN; Ji RR
J Neurosci; 2011 Dec; 31(50):18433-8. PubMed ID: 22171045
[TBL] [Abstract][Full Text] [Related]
3. The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn.
Zhou HY; Chen SR; Chen H; Pan HL
J Neurochem; 2009 Jan; 108(1):305-18. PubMed ID: 19012737
[TBL] [Abstract][Full Text] [Related]
4. TNF-α contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2.
Zhang L; Berta T; Xu ZZ; Liu T; Park JY; Ji RR
Pain; 2011 Feb; 152(2):419-427. PubMed ID: 21159431
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species enhance excitatory synaptic transmission in rat spinal dorsal horn neurons by activating TRPA1 and TRPV1 channels.
Nishio N; Taniguchi W; Sugimura YK; Takiguchi N; Yamanaka M; Kiyoyuki Y; Yamada H; Miyazaki N; Yoshida M; Nakatsuka T
Neuroscience; 2013 Sep; 247():201-12. PubMed ID: 23707800
[TBL] [Abstract][Full Text] [Related]
6. Endogenous transient receptor potential ankyrin 1 and vanilloid 1 activity potentiates glutamatergic input to spinal lamina I neurons in inflammatory pain.
Huang Y; Chen SR; Chen H; Pan HL
J Neurochem; 2019 May; 149(3):381-398. PubMed ID: 30716174
[TBL] [Abstract][Full Text] [Related]
7. The induction of long-term potentiation in spinal dorsal horn after peripheral nociceptive stimulation and contribution of spinal TRPV1 in rats.
Yang F; Guo J; Sun WL; Liu FY; Cai J; Xing GG; Wan Y
Neuroscience; 2014 Jun; 269():59-66. PubMed ID: 24680883
[TBL] [Abstract][Full Text] [Related]
8. Chronic pain models amplify transient receptor potential vanilloid 1 (TRPV1) receptor responses in adult rat spinal dorsal horn.
Uta D; Yoshimura M; Koga K
Neuropharmacology; 2019 Dec; 160():107753. PubMed ID: 31493465
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha sensitizes spinal cord TRPV1 receptors to the endogenous agonist N-oleoyldopamine.
Spicarova D; Palecek J
J Neuroinflammation; 2010 Aug; 7():49. PubMed ID: 20796308
[TBL] [Abstract][Full Text] [Related]
10. Shp-1 dephosphorylates TRPV1 in dorsal root ganglion neurons and alleviates CFA-induced inflammatory pain in rats.
Xiao X; Zhao XT; Xu LC; Yue LP; Liu FY; Cai J; Liao FF; Kong JG; Xing GG; Yi M; Wan Y
Pain; 2015 Apr; 156(4):597-608. PubMed ID: 25790452
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of glutamatergic synaptic transmission by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse.
Sikand P; Premkumar LS
J Physiol; 2007 Jun; 581(Pt 2):631-47. PubMed ID: 17363391
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 Receptors.
Mrozkova P; Spicarova D; Palecek J
PLoS One; 2016; 11(10):e0163991. PubMed ID: 27755539
[TBL] [Abstract][Full Text] [Related]
13. Opioid-induced long-term potentiation in the spinal cord is a presynaptic event.
Zhou HY; Chen SR; Chen H; Pan HL
J Neurosci; 2010 Mar; 30(12):4460-6. PubMed ID: 20335482
[TBL] [Abstract][Full Text] [Related]
14. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
15. The stress protein heat shock cognate 70 (Hsc70) inhibits the Transient Receptor Potential Vanilloid type 1 (TRPV1) channel.
Iftinca M; Flynn R; Basso L; Melo H; Aboushousha R; Taylor L; Altier C
Mol Pain; 2016; 12():. PubMed ID: 27558883
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.
Chakraborty S; Elvezio V; Kaczocha M; Rebecchi M; Puopolo M
J Physiol; 2017 Apr; 595(8):2639-2660. PubMed ID: 28094445
[TBL] [Abstract][Full Text] [Related]
17. The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect.
Fattori V; Pinho-Ribeiro FA; Staurengo-Ferrari L; Borghi SM; Rossaneis AC; Casagrande R; Verri WA
Br J Pharmacol; 2019 Jun; 176(11):1728-1744. PubMed ID: 30830967
[TBL] [Abstract][Full Text] [Related]
18. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties.
Gavva NR; Tamir R; Qu Y; Klionsky L; Zhang TJ; Immke D; Wang J; Zhu D; Vanderah TW; Porreca F; Doherty EM; Norman MH; Wild KD; Bannon AW; Louis JC; Treanor JJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):474-84. PubMed ID: 15615864
[TBL] [Abstract][Full Text] [Related]
19. TRPV1 receptor inhibition decreases CCL2-induced hyperalgesia.
Spicarova D; Adamek P; Kalynovska N; Mrozkova P; Palecek J
Neuropharmacology; 2014 Jun; 81():75-84. PubMed ID: 24495396
[TBL] [Abstract][Full Text] [Related]
20. Ht31 peptide inhibited inflammatory pain by blocking NMDA receptor-mediated nociceptive transmission in spinal dorsal horn of mice.
Wang WT; Pan GQ; Zhang ZY; Suo ZW; Yang X; Hu XD
Neuropharmacology; 2015 Feb; 89():290-7. PubMed ID: 25312281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
